Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2025-12-27 @ 4:29 AM
Study NCT ID:
NCT01589159
Status:
COMPLETED
Last Update Posted:
2017-02-27
First Post:
2012-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes
Sponsor:
Tao OUYANG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-28
First Submit QC Date:
None
Study First Post Date:
2012-05-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-24
Last Update Post Date:
2017-02-27
Last Update Post Date Type:
ACTUAL